Winslow Asset Management Inc. Boosts Position in Kenvue Inc. (NYSE:KVUE)

Winslow Asset Management Inc. lifted its stake in shares of Kenvue Inc. (NYSE:KVUEFree Report) by 22.7% during the 4th quarter, Holdings Channel reports. The fund owned 151,930 shares of the company’s stock after buying an additional 28,079 shares during the quarter. Winslow Asset Management Inc.’s holdings in Kenvue were worth $3,271,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. purchased a new position in shares of Kenvue during the 3rd quarter worth $2,944,816,000. Price T Rowe Associates Inc. MD raised its holdings in Kenvue by 19.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 109,327,221 shares of the company’s stock valued at $2,353,816,000 after buying an additional 18,118,056 shares during the period. FMR LLC raised its holdings in Kenvue by 572.1% in the 3rd quarter. FMR LLC now owns 89,182,980 shares of the company’s stock valued at $1,790,794,000 after buying an additional 75,913,107 shares during the period. Wellington Management Group LLP raised its holdings in Kenvue by 576.1% in the 3rd quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock valued at $1,439,472,000 after buying an additional 61,084,123 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its holdings in Kenvue by 9.1% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 66,665,454 shares of the company’s stock valued at $1,435,307,000 after buying an additional 5,574,265 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on KVUE shares. The Goldman Sachs Group started coverage on shares of Kenvue in a report on Friday, March 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. HSBC boosted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a report on Wednesday, May 8th. William Blair began coverage on Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating for the company. Citigroup reaffirmed a “neutral” rating and issued a $21.00 target price on shares of Kenvue in a research report on Tuesday, May 28th. Finally, Sanford C. Bernstein began coverage on Kenvue in a research report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 target price for the company. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $23.09.

Check Out Our Latest Report on KVUE

Kenvue Stock Down 0.5 %

Shares of Kenvue stock traded down $0.09 on Friday, reaching $17.94. 8,112,860 shares of the company were exchanged, compared to its average volume of 18,829,811. Kenvue Inc. has a 1-year low of $17.75 and a 1-year high of $26.74. The company has a market cap of $34.35 billion and a P/E ratio of 23.11. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.99 and a quick ratio of 0.68. The stock’s 50 day moving average price is $19.44 and its 200-day moving average price is $20.12.

Kenvue (NYSE:KVUEGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.03. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. The firm’s quarterly revenue was down 24.9% on a year-over-year basis. As a group, equities analysts forecast that Kenvue Inc. will post 1.18 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.46%. The ex-dividend date of this dividend was Tuesday, May 7th. Kenvue’s payout ratio is 102.56%.

Kenvue Company Profile

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Read More

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.